Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Jul 14, 2014 · 10-Q · 44 days after period end · 0001178913-14-002290
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | $1.83M | -$1.26M | -$550.37K | $457.37K |
| EPS Diluted | $0.18 | $0.17 | $0.09 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended May 31, 2014 · filed Jul 14, 2014 · 44 d after period end
